FindTrial
Sign In

Vaginal Ozone Insufflation in the Treatment of Recurrent Candidal Vulvovaginitis: Randomized Control Trial

Vaginal Ozone Insufflation in the Treatment of Recurrent Candidal Vulvovaginitis: Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202501712494218
Enrollment
50
Registered
2025-01-17
Start date
2018-02-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vulvovaginitis

Interventions

Antifungal treatment
ozone vaginal insufflatioin

Sponsors

ain shams university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (a) womenbetween 20 and 40 years of age (b) Subjects who were clinically diagnosed with recurrent vulvo-vaginitis with at least 6 months of refractory evolution to common pharmacologic treatment and positive cultures of candida albicans.

Exclusion criteria

Exclusion criteria: (a) Non-willingness of the subject to participate in the study (b) Pregnancy and lactation (c) Presence of other vaginal infections such as bacterial vaginosis

Design outcomes

Primary

MeasureTime frame
clinical improvement—

Secondary

MeasureTime frame
microbiological cure rate—

Countries

Egypt

Contacts

Public Contactahmed abdel hamid

professor

ahmedgyna@yahoo.com00201227960980

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026